<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04975373</url>
  </required_header>
  <id_info>
    <org_study_id>0002-21</org_study_id>
    <nct_id>NCT04975373</nct_id>
  </id_info>
  <brief_title>Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions</brief_title>
  <official_title>Reduction of Intrauterine Adhesions by Intrauterine Hyaluronic Acid Gel After Hysteroscopic Removal of Retained Products of Conception: Multicenter Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barzilai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women undergoing operative hysteroscopy for removal of retained placenta after delivery will&#xD;
      be randomized into two groups.&#xD;
&#xD;
        1. study group - immediately after operative hysteroscopy 5 ml hyaluronic acid gel will be&#xD;
           injected into uterine cavity&#xD;
&#xD;
        2. control group - no injection&#xD;
&#xD;
      4-8 weeks after operative hysteroscopy, participants will undergo diagnostic hysteroscopy&#xD;
      with no anesthesia , as a part of routine evaluation after removal of retained placenta in&#xD;
      Israel.&#xD;
&#xD;
      during diagnostic hysteroscopy the uterine cavity will be evaluated and the presence of&#xD;
      adhesions and severity of adhesions will be recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">July 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 25, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>any adhesions</measure>
    <time_frame>4-8 weeks after intervention</time_frame>
    <description>presence of any adhesions in uterine cavity during diagnostic hysteroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adhesion scorring</measure>
    <time_frame>4-8 weeks after intervention</time_frame>
    <description>American Fertility Society score for intrauterine adhesions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Prevenetion of Intrauterine Adhesions by Hyaluronic Acid Gel</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>study group women in this group will receive intrauterine hyaluronic acid injection after operative hysteroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>women will not receive hyaluronic acid after operative hysteroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrauterine injection of hyaluronic acid</intervention_name>
    <description>operative hysteroscopy - as a part of treatment in cases with retained placenta after delivery diagnostic hysteroscopy - as a routine evaluation after removal of placenta</description>
    <arm_group_label>study group</arm_group_label>
    <other_name>operative hysteroscopy -</other_name>
    <other_name>diagnostic hysteroscopy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women undergoing hysteroscopic removal of retained placenta after delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known adverse reaction or allergy to hyaluronic acid&#xD;
&#xD;
        History of intrauterine adhesions&#xD;
&#xD;
        Acute pelvic inflammatory disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Barzilai University Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>retained placenta</keyword>
  <keyword>operative hysteroscopy</keyword>
  <keyword>intrauterine adhesions</keyword>
  <keyword>hyaluronic acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

